My Medical Gateway Blog

When UK patients consider treatment abroad, the first question is not price. It is trust. Who is providing the care, and can it be relied upon? That question sits at the centre of My Medical Gateway’s model. Every hospital on the platform has passed through a structured, rigorous accreditation and onboarding process designed to ensure one outcome: consistent, high-quality care without uncertainty.

At MMG, accreditation is a controlled, multi-stage process that filters out any provider that does not meet clearly defined legal, clinical and operational standards. For UK patients, this matters. It means that every hospital visible on the platform has already been assessed, challenged and verified before you ever see it.

The starting point is jurisdiction. At the present time, MMG works exclusively with private hospitals located within the European Union for the UK market. This policy will adapt over time, of course, as the network grows to capture customers outside the UK, but for the UK market it ensures that all providers operate within a robust and familiar framework of EU regulation, clinical governance and patient protection.

Every hospital must be fully licensed and compliant with national and EU regulations. It must be accredited by at least one recognised insurance provider and demonstrate a consistent record of strong clinical performance. Providers with unresolved regulatory issues, sanctions or gaps in insurance are excluded outright.

Hospitals must also meet a series of operational and structural requirements that directly affect patient safety and outcomes. They must have permanent medical teams in place, capable of conducting remote diagnostics for international patients. Treatments must be carried out in facilities that are equipped with, or have immediate access to, full emergency care capabilities. They must also fully adopt MMG’s Treatment Package, ensuring a consistent and complete patient pathway from initial consultation through to post-treatment care.

These requirements are reinforced by MMG’s Healthcare Provider Terms & Conditions, which all accredited hospitals must accept in full. These terms set out strict obligations around clinical standards, patient care, ethical conduct and operational delivery. Importantly, they are available for any platform user to read, alongside the accreditation criteria themselves, allowing patients to assess directly the standards to which every provider is held (https://www.mymedicalgateway.com/mmg-hospital-tcs).

This level of transparency is deliberate. It reflects the depth of effort MMG has put into placing quality, patient safety and peace of mind at the centre of the platform. The onboarding process is designed to test all of this in practice.

It begins with a meeting between the hospital’s leadership and MMG’s senior management team. This is a detailed review of expectations, standards and alignment. Hospitals are provided with full documentation upfront, including platform requirements, legal frameworks and operational models. 

From there, the provider moves into a formal onboarding phase. This includes a detailed walkthrough of MMG’s platform and data requirements, covering treatment capabilities, pricing and institutional credentials. Hospitals must nominate a dedicated internal lead responsible for compiling and submitting this information, ensuring accountability from the outset. 

Legal engagement follows quickly. Providers are required to review and prepare to execute the Healthcare Provider Agreement and associated Terms & Conditions early in the process. In most cases, agreement must be reached within a few weeks of initial engagement. Providers that cannot meet this pace do not proceed.  This is intentional: it ensures that only committed and capable institutions that have given serious consideration to the needs of medical travellers move forward into partnership with MMG.

Commercial alignment is addressed in parallel. Hospitals must confirm the treatments they will offer, their pricing and their capacity to deliver, particularly in orthopaedics where UK demand is highest. Pricing must be competitive and consistent with the broader network. 

The final stage is a site visit by senior MMG management to meet the hospital’s leadership team, review the facility environment and verify that all operational processes and legal documentation are fully aligned with MMG requirements. Only once this stage is complete, and all conditions are satisfied, is the provider approved to join the platform.

Hospitals must confirm that they remain in good standing at all times, with no regulatory breaches, sanctions or changes to their operating status. They must maintain appropriate insurance coverage and continue to meet MMG’s standards across all treatments offered. Any change must be disclosed immediately.

For UK patients, the result is a controlled and transparent environment. You are not navigating an open marketplace of unknown providers. You are selecting from a curated network of hospitals that have met a clearly defined and consistently applied standard, and whose obligations are visible for you to review.

It is also important to understand that MMG’s policy is not designed to list the largest number of hospitals or to compete on the lowest possible price. There are low-cost providers in the market, particularly in areas such as cosmetic procedures. MMG does not operate in that space.

MMG’s focus is on quality, immediacy and certainty – at a fair and sustainable price. Patients using MMG are typically making time-sensitive decisions to restore mobility, return to work or address serious health issues. They require confidence in clinical outcomes, clarity on pricing and immediate access to treatment. That combination is only possible when the supply side is tightly controlled.

The accreditation and onboarding process is how that control is maintained. It ensures that every hospital on the platform is capable of delivering a consistent, high-quality treatment experience within a regulated and accountable framework. Trust in healthcare is not built through claims. It is built through process, transparency and verification. For UK patients considering treatment in Europe, that is exactly what MMG provides.